Osimertinib, Surgery, and Radiation Therapy in Treating Patients with Stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR)
Crossref DOI link: https://doi.org/10.1245/s10434-022-11627-9
Published Online: 2022-05-09
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khan, Tahsin M.
Verbus, Emily A.
Gandhi, Saumil
Heymach, John V.
Hernandez, Jonathan M.
Elamin, Yasir Y.
Text and Data Mining valid from 2022-05-09
Version of Record valid from 2022-05-09
Article History
Received: 17 December 2021
Accepted: 7 March 2022
First Online: 9 May 2022